Here's the link to the interview with Dr. Singh: http://www.virology.ws/2010/08/08/twiv-94-xmrv-with-dr-ila-singh/
Thank you Drs. Racaniello and Singh.
Take home message - We're working very hard on this but there is a lot that WE DON'T KNOW!
I have to say that Dr. Singh is my type of sober and serious scientist.
I have two pages of notes but in summary, Dr. Singh describes the CFS XMRV study that she is presently doing as a replication of the Science study plus additional types of testing. She also describes exchanging WPI subjects in a manner carefully designed to avoid any chance of contamination.
Dr. Singh has not closed the door on anything at this point, nor is she jumping to any conclusions. She does point carefully to the importance of methodology and to the difficulty of detecting XMRV because of very low copy numbers and uncertainty about reservoirs.
Thank you Drs. Racaniello and Singh.
Take home message - We're working very hard on this but there is a lot that WE DON'T KNOW!
I have to say that Dr. Singh is my type of sober and serious scientist.
I have two pages of notes but in summary, Dr. Singh describes the CFS XMRV study that she is presently doing as a replication of the Science study plus additional types of testing. She also describes exchanging WPI subjects in a manner carefully designed to avoid any chance of contamination.
Dr. Singh has not closed the door on anything at this point, nor is she jumping to any conclusions. She does point carefully to the importance of methodology and to the difficulty of detecting XMRV because of very low copy numbers and uncertainty about reservoirs.
